SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-002222
Filing Date
2021-03-02
Accepted
2021-03-02 08:31:41
Documents
74
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K glyc-20201231x10k.htm   iXBRL 10-K 1795252
2 EX-23.1 glyc-20201231xex23d1.htm EX-23.1 9373
3 EX-31.1 glyc-20201231xex31d1.htm EX-31.1 11507
4 EX-31.2 glyc-20201231xex31d2.htm EX-31.2 11824
5 EX-32.1 glyc-20201231xex32d1.htm EX-32.1 9312
6 GRAPHIC glyc-20201231x10k006.jpg GRAPHIC 60898
7 GRAPHIC glyc-20201231x10k007.jpg GRAPHIC 49388
  Complete submission text file 0001558370-21-002222.txt   6867502

Data Files

Seq Description Document Type Size
8 EX-101.SCH glyc-20201231.xsd EX-101.SCH 43431
9 EX-101.CAL glyc-20201231_cal.xml EX-101.CAL 51911
10 EX-101.DEF glyc-20201231_def.xml EX-101.DEF 168885
11 EX-101.LAB glyc-20201231_lab.xml EX-101.LAB 371271
12 EX-101.PRE glyc-20201231_pre.xml EX-101.PRE 341966
13 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20201231x10k_htm.xml XML 1051586
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36177 | Film No.: 21701374
SIC: 2834 Pharmaceutical Preparations